A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 86,797 shares of CPRX stock, worth $1.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
86,797
Previous 105,535 17.76%
Holding current value
$1.84 Million
Previous $1.63 Million 5.57%
% of portfolio
0.0%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$15.19 - $21.35 $284,630 - $400,056
-18,738 Reduced 17.76%
86,797 $1.73 Million
Q2 2024

Aug 14, 2024

SELL
$14.68 - $16.92 $103,993 - $119,861
-7,084 Reduced 6.29%
105,535 $1.63 Million
Q1 2024

May 09, 2024

BUY
$13.18 - $17.11 $12,586 - $16,340
955 Added 0.86%
112,619 $1.8 Million
Q2 2023

Aug 08, 2023

SELL
$11.5 - $18.08 $1,150 - $1,807
-100 Reduced 0.09%
111,664 $1.5 Million
Q1 2023

May 01, 2023

SELL
$14.34 - $21.05 $312,669 - $458,974
-21,804 Reduced 16.32%
111,764 $1.85 Million
Q4 2022

Feb 03, 2023

SELL
$12.25 - $19.5 $1.93 Million - $3.07 Million
-157,329 Reduced 54.08%
133,568 $2.48 Million
Q2 2022

Aug 09, 2022

BUY
$6.23 - $8.57 $189,572 - $260,776
30,429 Added 11.68%
290,897 $2.04 Million
Q1 2022

May 05, 2022

SELL
$5.31 - $8.31 $26,996 - $42,248
-5,084 Reduced 1.91%
260,468 $2.16 Million
Q4 2021

Feb 02, 2022

BUY
$5.21 - $7.45 $332,142 - $474,944
63,751 Added 31.59%
265,552 $1.8 Million
Q3 2021

Oct 26, 2021

BUY
$4.85 - $6.04 $978,734 - $1.22 Million
201,801 New
201,801 $1.07 Million

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.17B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.